Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Prospective, Double-Blind, Multicenter Study Evaluating the Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
The purpose of this study was to assess the safety of repeat doses of serelaxin in chronic heart failure.
Key Inclusion Criteria:
Key Exclusion Criteria:
Diskapi / Ankara, 06110, Turkey (Türkiye)
Haydarpasa/Istanbul, 34668, Turkey (Türkiye)
Meselik / Eskisehir, 26480, Turkey (Türkiye)